Drugs / RSV F protein
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01960686 | Oct 2013 → Apr 2014 | respiratory syncytial virus infectious disease | Novavax | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RSV F protein | “one dose of 120μg RSV F protein and 0.4mg aluminum” PMID 28579233 ↗ Jun 2017 |
| Modality | Vaccine | “RSV F protein nanoparticle vaccine” NCT01960686 ↗ |